Business Context and Reporting Period
Company: Kewaunee Scientific Corporation (KEQU)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended January 31, 2025
Business Overview: The Company designs, manufactures, and installs scientific and technical furniture. A material event during the period was the acquisition of Nu Aire, Inc. on November 1, 2024, for approximately $53.0 million in aggregate consideration. This acquisition expanded the Company's domestic capabilities in laboratory equipment, including biological safety cabinets and CO2 incubators.
Key Financial Metrics
| Metric ($ in thousands) | 3 Months Ended Jan 31, 2025 | 3 Months Ended Jan 31, 2024 | 9 Months Ended Jan 31, 2025 | 9 Months Ended Jan 31, 2024 |
|---|---|---|---|---|
| Net Sales | $67,167 | $46,778 | $163,324 | $147,053 |
| Gross Profit | $18,379 | $12,029 | $44,819 | $37,411 |
| Gross Margin % | 27.4% | 25.7% | 27.4% | 25.4% |
| Operating Profit | $2,250 | $3,806 | $9,259 | $12,723 |
| Net Earnings (Attributable to Kewaunee) | $1,354 | $2,521 | $6,555 | $7,727 |
| Diluted EPS | $0.45 | $0.85 | $2.20 | $2.64 |
| Cash from Operations (9 Months) | $5,376 (2025) vs $18,419 (2024) | |||
| Working Capital | $58,441 (Jan 31, 2025) vs $56,037 (Apr 30, 2024) | |||
| Total Debt (Long-term + Current) | ~$65.6M (Includes $23.5M Seller Notes, $14.5M PNC Loan, $27.6M Sale-Leaseback) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 43.6% for the quarter and 11.1% for the nine-month period. Domestic sales surged 63.6% in the quarter, driven primarily by the inclusion of Nu Aire results and higher manufacturing volumes. International sales were flat for the quarter (+1.2%) but declined 13.7% for the nine-month period due to construction delays in India.
- Profitability Decline: Despite revenue growth, Net Earnings decreased 46.3% for the quarter and 15.2% for the nine-month period. Operating expenses increased significantly (95.7% for the quarter) due to Nu Aire integration costs, higher consulting fees, and increased stock-based compensation.
- Interest Expense: Interest expense rose to $1.137 million for the quarter (from $0.411 million) and $2.051 million for the nine months (from $1.213 million), reflecting new debt incurred for the acquisition and higher interest rates.
- Tax Rate: The effective tax rate dropped to (8.5)% for the quarter and 13.1% for the nine months, compared to 27.9% and 33.1% in the prior year, aided by a discrete tax benefit of $421,000 from stock issuances.
- Balance Sheet: Total assets increased to $189.1 million from $134.8 million, largely due to the acquisition of Nu Aire, which added $14.2 million in goodwill and $18.2 million in intangible assets.
Guidance, Outlook, and Risks
- Outlook: Management cites a strong order backlog of $221.6 million (up from $152.3 million a year ago). The Company expects the Nu Aire acquisition to accelerate its vision of becoming a market leader in laboratory furniture. Demand remains dependent on laboratory construction projects and raw material costs (steel, wood, epoxy resin).
- Liquidity: The Company terminated its previous Mid Cap Revolving Credit Facility in September 2024 and entered a new agreement with PNC Bank, featuring a $20.0 million revolving line and a $15.0 million term loan. Cash and cash equivalents stood at $9.5 million as of January 31, 2025.
- Risks:
- Integration Risk: Challenges in realizing anticipated synergies from the Nu Aire acquisition.
- Impairment Risk: Goodwill ($14.2 million) and intangible assets ($18.2 million) recorded from the acquisition could be impaired in the future.
- International Delays: Continued project delays in India impacting international segment revenue.
- Commodity Costs: Fluctuations in raw material prices affecting margins.
Investor Verification Checklist
- Acquisition Integration: Verify the timeline and cost of integrating Nu Aire's operations and systems, and whether projected synergies are being realized.
- Debt Servicing: Confirm the Company's ability to service the new debt load, including the $23.0 million in seller notes (8% interest) and the PNC term loan, given the decline in operating profit.
- International Segment: Monitor the status of delayed construction projects in India and their impact on future revenue recognition.
- Operating Expense Trajectory: Assess whether the significant increase in operating expenses (consulting, professional fees) is temporary or indicative of a new, higher cost structure.
- Backlog Conversion: Track the conversion rate of the $221.6 million order backlog into recognized revenue in upcoming quarters.